Cargando…

Different effects of low muscle mass on the risk of non‐alcoholic fatty liver disease and hepatic fibrosis in a prospective cohort

BACKGROUND: Non‐alcoholic fatty liver disease (NAFLD) and sarcopenia share insulin resistance as a common pathophysiology and have overlapping clinical manifestation of metabolic derangement; hence, it is difficult to differentiate the independent effect of sarcopenia on the development of NAFLD fro...

Descripción completa

Detalles Bibliográficos
Autores principales:	Choe, Hun Jee, Lee, Hyunsuk, Lee, DongHo, Kwak, Soo‐Heon, Koo, Bo Kyung
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9891951/ https://www.ncbi.nlm.nih.gov/pubmed/36403577 http://dx.doi.org/10.1002/jcsm.13125

Ejemplares similares

RF17 | P715 Contribution of Low Muscle Mass and Genetic Factors in NAFLD and Liver Cirrhosis
por: Choe, Hun Jee, et al.
Publicado: (2022)

Association between muscle strength and advanced fibrosis in non‐alcoholic fatty liver disease: a Korean nationwide survey
por: Kang, Sunyoung, et al.
Publicado: (2020)

Relationship between Muscle Mass and Non-Alcoholic Fatty Liver Disease
por: Lee, Jun-Hyuk, et al.
Publicado: (2021)

Association between telomere length and hepatic fibrosis in non-alcoholic fatty liver disease
por: Shin, Hee Kyung, et al.
Publicado: (2021)

Association Between Skeletal Muscle Mass and Severity of Steatosis and Fibrosis in Non-alcoholic Fatty Liver Disease
por: Guo, Wen, et al.
Publicado: (2022)

Complements are involved in alcoholic fatty liver disease, hepatitis and fibrosis
por: Lin, Cheng-Jie, et al.
Publicado: (2018)

Association of Muscle Strength with Non-Alcoholic Fatty Liver Disease in Korean Adults
por: Lee, Sung-Bum, et al.
Publicado: (2022)

Exploration of new therapeutic targets for viral hepatic fibrosis, alcoholic hepatic fibrosis, and non-alcoholic hepatic fibrosis
por: Wang, Xiaoling, et al.
Publicado: (2022)

Hepatic Unsaturated Fatty Acids Are Linked to Lower Degree of Fibrosis in Non-alcoholic Fatty Liver Disease
por: Fridén, Michael, et al.
Publicado: (2022)

The Association between Nonalcoholic Fatty Liver Disease and CT-Measured Skeletal Muscle Mass
por: Choe, Eun Kyung, et al.
Publicado: (2018)

Periodontitis is associated with significant hepatic fibrosis in patients with non-alcoholic fatty liver disease
por: Alazawi, William, et al.
Publicado: (2017)

The risk of atrial fibrillation in patients with non-alcoholic fatty liver disease and a high hepatic fibrosis index
por: Park, Hyo Eun, et al.
Publicado: (2020)

Assessment of Diabetic Polyneuropathy and Autonomic Neuropathy Using Current Perception Threshold in Korean Patients with Diabetes Mellitus
por: Koo, Bo Kyung, et al.
Publicado: (2014)

Thoracic skeletal muscle quantification: low muscle mass is related with worse prognosis in idiopathic pulmonary fibrosis patients
por: Moon, Sung Woo, et al.
Publicado: (2019)

Comparison of Prevailing Insulin Regimens at Different Time Periods in Hospitalized Patients: A Real-World Experience from a Tertiary Hospital
por: Moon, Sun Joon, et al.
Publicado: (2022)

Association of Skeletal Muscle and Adipose Tissue Distribution with Histologic Severity of Non-Alcoholic Fatty Liver
por: Kang, Min-Kyu, et al.
Publicado: (2021)

Impact of Evolutionary Changes in Nonalcoholic Fatty Liver Disease on Lung Function Decline
por: Lee, Hyun Woo, et al.
Publicado: (2023)

Association between small dense LDL levels and hepatic fibrosis in patients with nonalcoholic fatty liver disease
por: Young Kim, Sun, et al.
Publicado: (2022)

The Differential Effect of Excess Aldosterone on Skeletal Muscle Mass by Sex
por: Kwak, Mi Kyung, et al.
Publicado: (2019)

Metabolic Score for Insulin Resistance Is Inversely Related to Incident Advanced Liver Fibrosis in Patients with Non-Alcoholic Fatty Liver Disease
por: Lee, Jun-Hyuk, et al.
Publicado: (2022)

Serum autotaxin levels are correlated with hepatic fibrosis and ballooning in patients with non-alcoholic fatty liver disease
por: Fujimori, Naoyuki, et al.
Publicado: (2018)

Risk factors for hepatic steatosis in adults with cystic fibrosis: Similarities to non-alcoholic fatty liver disease
por: Ayoub, Fares, et al.
Publicado: (2018)

Inhibiting Ceramide Synthesis Attenuates Hepatic Steatosis and Fibrosis in Rats With Non-alcoholic Fatty Liver Disease
por: Jiang, Meng, et al.
Publicado: (2019)

Inflammation and fibrosis in chronic liver diseases including non-alcoholic fatty liver disease and hepatitis C
por: Tanwar, Sudeep, et al.
Publicado: (2020)

Association of Low Skeletal Muscle Mass with the Phenotype of Lean Non-Alcoholic Fatty Liver Disease
por: Byeon, Jun-Hyeon, et al.
Publicado: (2022)

Which Index for Muscle Mass Represents an Aging Process?
por: Kim, Hyung-Kook, et al.
Publicado: (2018)

Muscle Function is Associated With Presence, New-onset, or Worsening of Hepatic Steatosis Assessed by Biochemical Parameters, Independent of Muscle Mass
por: Hong, Namki, et al.
Publicado: (2021)

T2(*) Mapping from Multi-Echo Dixon Sequence on Gadoxetic Acid-Enhanced Magnetic Resonance Imaging for the Hepatic Fat Quantification: Can It Be Used for Hepatic Function Assessment?
por: Yoo, Hyunsuk, et al.
Publicado: (2017)

Reappraisal of fibrosis-4 index and non-alcoholic fatty liver disease fibrosis score for advanced fibrosis in average-risk population
por: Park, Huiyul, et al.
Publicado: (2022)

Change in skeletal muscle mass is associated with hepatic steatosis in nonalcoholic fatty liver disease
por: Jo, Ik Hyun, et al.
Publicado: (2023)

Fat mass to fat-free mass ratio and the risk of non-alcoholic fatty liver disease and fibrosis in non-obese and obese individuals
por: Dai, Huajie, et al.
Publicado: (2021)

Markers of Inflammation and Fibrosis in Alcoholic Hepatitis and Viral Hepatitis C
por: Neuman, Manuela G., et al.
Publicado: (2012)

Dietary inflammatory index and risk of non-alcoholic fatty liver disease and advanced hepatic fibrosis in US adults
por: Zhang, Zhongmian, et al.
Publicado: (2023)

Progressive reduction in skeletal muscle mass to visceral fat area ratio is associated with a worsening of the hepatic conditions of non-alcoholic fatty liver disease
por: Shida, Takashi, et al.
Publicado: (2019)

Prognostic Value of the Alcoholic Hepatitis Histologic Score in Korean Patients with Biopsy-Proven Alcoholic Hepatitis
por: Lee, Dong Hyeon, et al.
Publicado: (2020)

CCL20 is up-regulated in non-alcoholic fatty liver disease fibrosis and is produced by hepatic stellate cells in response to fatty acid loading
por: Chu, Xin, et al.
Publicado: (2018)

Liquid Biopsy for the Diagnosis of Viral Hepatitis, Fatty Liver Steatosis, and Alcoholic Liver Diseases
por: Shabangu, Ciniso Sylvester, et al.
Publicado: (2020)

Serum prohepcidin levels in chronic hepatitis C, alcoholic liver disease, and nonalcoholic fatty liver disease
por: Lee, Sang Hyub, et al.
Publicado: (2010)

Muscle strength, but not body mass index, is associated with mortality in patients with non‐alcoholic fatty liver disease
por: Charatcharoenwitthaya, Phunchai, et al.
Publicado: (2022)

Progressive Liver Fibrosis in Non-Alcoholic Fatty Liver Disease
por: Ramai, Daryl, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_fvts05t6qmncg6ud6di6vh1q43